Today: 28 February 2026
Subscribe
Browse Category

Dividends 13 December 2025 - 14 December 2025

Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025

Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025

Merck shares closed at $100.30 on Dec. 12, ahead of the Dec. 15 ex-dividend date for a $0.85 quarterly payout. The stock sits 5.2% below its 52-week high, with Friday’s volume at 11.8 million shares, under the 50-day average. Investors are watching the impact of the dividend reset and ongoing developments around Keytruda and RSV products.
14 December 2025
·
JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase shares closed Friday near $318, just below their 52-week high, after management projected 2026 expenses of about $105 billion—well above analyst expectations. The stock dropped 4–5% following the announcement, marking its sharpest decline in months. Investors are weighing the impact of increased spending on AI, marketing, and expansion ahead of upcoming earnings.
14 December 2025
··
Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025)

Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025)

Pfizer shares closed at $25.85, below their 52-week high but above the low. The company declared a $0.43 first-quarter 2026 dividend, its 349th consecutive payout. Investors await Tuesday’s analyst call, where management will issue full-year 2026 guidance. A new obesity drug licensing deal with YaoPharma was also announced.
14 December 2025
··
SSE (LSE:SSE) Share Price This Week: Ofgem Grid Decisions, Scrip Dividend Update, and Analyst Targets — Outlook for the Week Ahead (Updated 14.12.2025)

SSE (LSE:SSE) Share Price This Week: Ofgem Grid Decisions, Scrip Dividend Update, and Analyst Targets — Outlook for the Week Ahead (Updated 14.12.2025)

SSE plc shares closed at 2,108p on Friday, 12 December 2025. Ofgem approved £28bn in initial investment for UK energy networks and set new delivery dates for key transmission projects involving SSE. The regulator’s RIIO-3 decision and project incentives remain central to SSE’s revenue outlook.
14 December 2025
···
HSBC Holdings Plc Stock (HSBA/HSBC) Outlook: Share Price Jumps, Dividend Week Looms, and Fresh Headlines Test the Rally (Updated 14 Dec 2025)

HSBC Holdings Plc Stock (HSBA/HSBC) Outlook: Share Price Jumps, Dividend Week Looms, and Fresh Headlines Test the Rally (Updated 14 Dec 2025)

HSBC shares rose 4.4% in London and 5.6% in New York last week, closing Friday at 1,111.8p and $74.99, respectively. The gains followed reports of a $300 million settlement in a French tax probe and the end of the bank’s 160-year-old International Manager program. A dividend payment, Bank of England rate decision, and key inflation data are due this week.
14 December 2025
···
Shell (SHEL) Stock Outlook: Latest News, Dividend, Buyback, Forecasts and Week-Ahead Catalysts (Updated Dec. 14, 2025)

Shell (SHEL) Stock Outlook: Latest News, Dividend, Buyback, Forecasts and Week-Ahead Catalysts (Updated Dec. 14, 2025)

Shell’s U.S. ADR closed at $72.33 on Dec. 13. Reuters reported Shell is in advanced talks to buy LLOG Exploration Offshore for over $3 billion, aiming to boost Gulf of Mexico output. The company is also seeking a buyer for a 20% stake in Brazil’s Gato do Mato project. Ongoing M&A moves and portfolio reshuffling are driving investor focus.
14 December 2025
···
Transurban Group Ltd (ASX: TCL) Stock Update: West Gate Tunnel Opens, NSW Toll Reform Moves, Dividend Outlook and Week-Ahead Catalysts (Updated 14 Dec 2025)

Transurban Group Ltd (ASX: TCL) Stock Update: West Gate Tunnel Opens, NSW Toll Reform Moves, Dividend Outlook and Week-Ahead Catalysts (Updated 14 Dec 2025)

Transurban opened Melbourne’s West Gate Tunnel to traffic on December 14, marking a major new toll route. The company last closed at A$14.65, down 2.27% over five days but up 9.41% for the year. New South Wales toll reform also advanced. The ex-distribution date approaches in late December.
14 December 2025
··
ANZ Group Holdings (ASX: ANZ) Stock: This Week’s Key Catalysts, Dividend, AGM Pay Vote — and the Week-Ahead Outlook (Updated 14 Dec 2025)

ANZ Group Holdings (ASX: ANZ) Stock: This Week’s Key Catalysts, Dividend, AGM Pay Vote — and the Week-Ahead Outlook (Updated 14 Dec 2025)

ANZ shares closed at A$35.81 on Friday, 8% below their November high, as the bank faces a lawsuit from former CEO Shayne Elliott over cancelled bonuses and proxy advisers urge shareholders to reject its pay report at the 18 December AGM. The final dividend payment is due soon. Market cap stands near A$107 billion. The Reserve Bank of Australia is signalling caution as inflation picks up.
14 December 2025
··
Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (NYSE: MPW) closed the week at about $5.10, down nearly 7% after a sharp 5.35% drop Thursday. The decline followed renewed scrutiny of tenant Prospect Medical’s finances and news that MPW will pay $7.65 million in a Waterbury hospital tax settlement. No major company press releases were issued during the week.
14 December 2025
·
Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Pfizer shares closed at $25.85 Friday, up 0.19%, after announcing a global obesity drug deal with YaoPharma and reporting positive Phase 3 data for breast cancer drug Tukysa. The company also highlighted strong hemophilia trial results and declared a $0.43 per share dividend, payable March 6, 2026. Trading volume reached about 23 million shares.
13 December 2025
···
Applied Materials (AMAT) Stock This Week: New 52-Week High, Sudden Pullback, Dividend News, and What to Watch Next Week (Updated Dec. 12, 2025)

Applied Materials (AMAT) Stock This Week: New 52-Week High, Sudden Pullback, Dividend News, and What to Watch Next Week (Updated Dec. 12, 2025)

Applied Materials shares fell 4.04% Friday to $259.21, erasing earlier gains after hitting a 52-week high of $276.10 on Wednesday. The stock dropped 3.34% for the week amid broad weakness in chip stocks following Broadcom’s post-earnings slide. Trading volume Friday was 6.6 million shares, below the 50-day average. The company also declared a $0.46 quarterly dividend payable March 12, 2026.
13 December 2025
··
Mastercard (MA) Stock Outlook: $14B Buyback, Dividend Hike and New Partnerships Fuel a Strong Week — What to Watch Next (Updated Dec. 12, 2025)

Mastercard (MA) Stock Outlook: $14B Buyback, Dividend Hike and New Partnerships Fuel a Strong Week — What to Watch Next (Updated Dec. 12, 2025)

Mastercard shares rose 5.8% this week, closing Friday at $571.93 after the company announced a $14 billion buyback authorization and a 14% dividend increase. The rally followed new partnerships in digital wallets, remittances, and travel payments, and came as the Federal Reserve cut rates by 25 basis points.
13 December 2025
··
1 … 21 22 23 24 25 … 39
Go toTop